The importance of the spliceosome machinery in leukemogenesis has been demonstrated [70, 72] and mutations in U2AF1 were recently shown to predict poor prognosis in patients with de novo acute myeloid leukemia [73]. Here, U2AF1 is linked to acute myeloid leukemia.